Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UTime
Shenzhen, Guangdong, Chinautimeworld.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
UTime is a Shenzhen-based company with a long history in low-cost mobile technology, since 2024 actively transforming health and wellness via innovative wearable medical devices. UTime is progressing toward acquisition of Bowen Therapeutics, which will add advanced vaccine R&D expertise (notably in the monkeypox vaccine field). No public clinical trial efficacy results have been disclosed as of August 2025.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineDevice
- Industry
- Biotech
02
Partnerships
Collaboration with Dr. Ehud Baron (noted medical expert)Partnership discussions with clinical trial organizations for vaccines
Beyond the preview
Go deeper on UTime.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UTime.